AN2 THERAPEUTICS RECEIVES CONTINUATION GRANT TO DISCOVER NOVEL BORON BASED THERAPIES FOR TUBERCULOSIS (CAUSED BY MYCOBACTERIUM TUBERCULOSIS) AND MALARIA

Reuters · 10/17 11:00

Please log in to view news